Profiling for novel proteomics biomarkers in neurodevelopmental disorders

Expert Review of Proteomics

Volumn 8, Issue 1, 2011, Pages 127-136

  Dudley, Ed ^a   Häßler, Frank ^b   Thome, Johannes ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

ADHD; autism; biomarker; CSF; proteomics; serum; urine

Indexed keywords

ADIPONECTIN; ALBUMIN; INSULIN; LEPTIN; NEUROTROPHIC FACTOR; PEPTIDE;

ATTENTION DEFICIT DISORDER; AUTISM; BINDING AFFINITY; CLINICAL PROTOCOL; DISEASE MARKER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MENTAL DISEASE; NEUROLOGIC DISEASE; NEUROTRANSMISSION; PEPTIDOMICS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEOMICS; REVIEW;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; BIOLOGICAL MARKERS; GENE EXPRESSION PROFILING; HUMANS; PROTEINS; PROTEOMICS;

EID: 79951880794     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/epr.10.97     Document Type: Review

References (59)

1. Solassol J, Rouanet P, Lamy PJ et al. Serum protein signature may improve detection of ductal carcinoma in situ of the breast. Oncogene 29(4), 550-560 (2010).
2. Yang Y, Zhao S, Fan Y et al. Detection and identification of potential biomarkers of non-small cell lung cancer. Technol. Cancer Res. Treat. 8(6), 455-466 (2009).
3. Al-Ruwaili JA, Larkin SE, Zeidan BA et al. Discovery of serum protein biomarkers for prostate cancer progression by proteomic analysis. Cancer Genomics Proteomics 7(2), 93-103 (2010).
4. Guo J, Sun Z, Xiao S et al. Proteomic analysis of the cerebrospinal fluid of Parkinsons disease patients. Cell Res. 19(12), 1401-1403 (2009).
5. Novikova SI, He F, Cutrufello NJ, Lidow MS. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis. Neurobiol. Dis. 23(1), 61-76 (2006). (Pubitemid 44192384)
6. Villemagne VL, Perez KA, Pike KE et al. Blood-borne amyloid-b dimer correlates with clinical markers of Alzheimers disease. J. Neurosci. 30(18), 6315-6322 (2010).
7. Snow A, Gozal D, Valdes R Jr, Jortani SA. Urinary proteins for the diagnosis of obstructive sleep apnea syndrome. Methods Mol. Biol. 641, 325-346 (2010).
8. Paweletz CP, Wiener MC, Bondarenko AY et al. Application of an end-to-end biomarker discovery platform to identify target engagement markers in cerebrospinal fluid by high resolution differential mass spectrometry. J. Proteome Res. 9(3), 1392-1401 (2010).
9. Wang H, Malone JP, Gilmore PE et al. Serum markers may distinguish biliary atresia from other forms of neonatal cholestasis. J. Pediatr. Gastroenterol. Nutr. 50(4), 411-416 (2010).
10. Magagnotti C, Fermo I, Carletti RM, Ferrari M, Bachi A. Comparison of different depletion strategies for improving resolution of the human urine proteome. Clin. Chem. Lab. Med. 48(4), 531-535 (2010).
11. Siegmund R, Kiehntopf M, Deufel T. Evaluation of two different albumin depletion strategies for improved analysis of human CSF by SELDI-TOF-MS. Clin. Biochem. 42 (10-11), 1136-1143 (2009).
12. Mahn A, Reyes A, Zamorano M, Cifuentes W, Ismail M. Depletion of highly abundant proteins in blood plasma by hydrophobic interaction chromatography for proteomic analysis. J. Chrom. B. 878(15-16), 1038-1044 (2010).
13. Taurines R, Dudley E, Conner AC et al. Serum protein profiling and proteomics in autistic spectrum disorder using magnetic bead-assisted mass spectrometry. Eur. Arch. Psychiatry Clin. Neurosci. 260(3), 249-255 (2010).
14. Kay R, Barton C, Ratcliffe L et al. Enrichment of low molecular weight serum proteins using acetonitrile precipitation for mass spectrometry based proteomic analysis. Rap. Comm. Mass Spec. 22(20), 3255-3260 (2008).
15. Nanni P, Levander F, Roda G, Caponi A, James P, Roda A. A label-free nano-liquid chromatography-mass spectrometry approach for quantitative serum peptidomics in Crohns disease patients. J. Chrom. B. 877(27), 3127-3136 (2009).
16. Harmsen MM, Jansen J, Westra DF, Coco-Martin JM. Characterization of foot-and-mouth disease virus antigen by surface-enhanced laser desorption ionization-time of flight-mass spectrometry in aqueous and oil-emulsion formulations. Vaccine 28(19), 3363-3370 (2010).
17. Zhang Q, Wang J, Dong R, Yang S, Zheng S. Identification of novel serum biomarkers in child nephroblastoma using proteomics technology. Mol. Biol. Rep. 38(1), 631-638 (2010).
18. Lu HB, Zhou JH, Ma YY et al. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer. Jpn. J. Clin. Oncol. 40(4), 336-342 (2010).
19. Pradeep AR, S TM, Garima G, Raju A. Serum levels of oncostatin M (a gp 130 cytokine): an inflammatory biomarker in periodontal disease. Biomarkers 15(3), 277-282 (2010).
20. Zhen H, Yang S, Wu H et al. LyGDI is a promising biomarker for ovarian cancer. Int. J. Gynecol. Cancer. 20(3), 316-322 (2010).
21. Hellstrom I, Heagerty PJ, Swisher EM et al. Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms. Cancer Lett. 296(1), 43-48 (2010).
22. Wu CC, Peng PH, Chang YT et al. Identification of potential serum markers for nasopharyngeal carcinoma from a xenografted mouse model using Cy-dye labeling combined with three-dimensional fractionation. Proteomics 8(17), 3605-3620 (2008).
23. Diz AP, Dudley E, Macdonald BW et al. Genetic variation underlying protein expression in eggs of the marine mussel Mytilus edulis. Mol. Cell Proteomics 8, 132-144 (2009).
24. OHayre M, Salanga CL, Dorrestein PC, Handel TM. Phosphoproteomic analysis of chemokine signaling networks. Methods Enzymol. 460, 331-346 (2009).
25. Ding S, Bond AE, Lemiere F et al. Online immobilized metal affinity chromatography/ mass spectrometry analysis of changes elicited by cCMP in the murine brain phosphoproteome. Rap. Comm. Mass Spec. 22(24), 4129-4138 (2008).
26. Bond AE, Dudley E, Tuytten R et al. Identification of Raβ23 phosphorylation as a response to challenge by cytidine 3′5′-cyclic monophosphate, a putative second messenger, in mouse brain. Rapid Comm. Mass Spec. 21(16), 2685-2692 (2007). (Pubitemid 47255482)
27. Cirulli C, Chiappetta G, Marino G, Mauri P, Amoresano A. Identification of free phosphopeptides in different biological fluids by a mass spectrometry approach. Anal. Bioanal. Chem. 392 (1-2), 147-159 (2008).
28. Abbott KL, Lim JM, Wells L, Benigno BB, McDonald JF, Pierce M. Identification of candidate biomarkers with cancer-specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysis. Proteomics 10(3), 470-481 (2010).
29. Liu Y, He J, Li C et al. Identification and confirmation of biomarkers using an integrated platform for quantitative analysis of glycoproteins and their glycosylations. J. Proteome Res. 9(2), 798-805 (2010).
30. Haqqani AS, Hutchison JS, Ward R, Stanimirovic DB. Biomarkers and diagnosis; protein biomarkers in serum of pediatric patients with severe traumatic brain injury identified by ICAT-LC-MS/ MS. J. Neurotrauma 24(1), 54-74 (2007). (Pubitemid 46214412)
31. Kang UB, Ahn Y, Lee JW. Differential profiling of breast cancer plasma proteome by isotope-coded affinity tagging method reveals biotinidase as a breast cancer biomarker. BMC Cancer 10, 114 (2010).
32. Kolla V, Jenö P, Moes S et al. Quantitative proteomics analysis of maternal plasma in Down syndrome pregnancies using isobaric tagging reagent (iTRAQ). J. Biomed. Biotechnol. 2010, 952047 (2010).
33. Zhou L, Beuerman RW, Chan CM et al. Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics. J. Proteome Res. 8(11), 4889-4905 (2009).
34. Nelson PG, Kuddo T, Song EY et al. Selected neurotrophins, neuropeptides, and cytokines: developmental trajectory and concentrations in neonatal blood of children with autism or Down syndrome. Int. J. Neurosci. 24(1), 73-80 (2006). (Pubitemid 43287950)
35. Vellaichamy A, Tran JC, Catherman AD et al. Size-sorting combined with improved nanocapillary liquid chromatography-mass spectrometry for identification of intact proteins up to 80 kDa. Anal. Chem. 82(4), 1234-1244 (2010).
36. Lee JE, Kellie JF, Tran JC et al. A robust two-dimensional separation for top-down tandem mass spectrometry of the low-mass proteome. J. Am. Soc. Mass Spectrom. 20(12), 2183-2191 (2009).
37. Riikonen R, Makkonen I, Vanhala R, Turpeinen U, Kuikka J, Kokki H. Cerebrospinal fluid insulin-like growth factors IGF-1 and IGF-2 in infantile autism. Dev. Med. Child Neurol. 48(9), 751-757 (2006).
38. Emanuele E, Orsi P, Barale F, di Nemi SU, Bertona M, Politi P. Serum levels of vascular endothelial growth factor and its receptors in patients with severe autism. Clin. Biochem. 43(3), 317-319 (2010).
39. Boso M, Emanuele E, Politi P et al. Reduced plasma apelin levels in patients with autistic spectrum disorder. Arch Med Res. 38(1), 70-74 (2007). (Pubitemid 44894612)
40. Fujita-Shimizu A, Suzuki K, Nakamura K et al. Decreased serum levels of adiponectin in subjects with autism. Prog. Neuropsychopharmacol. Biol. Psychiatry 34(3), 455-458 (2010).
41. Kajizuka M, Miyachi T, Matsuzaki H et al. Serum levels of platelet-derived growth factor BB homodimers are increased in male children with autism. Prog. Neuropsychopharmacol. Biol. Psychiatry 34(1), 154-158 (2010).
42. Iwata Y, Tsuchiya KJ, Mikawa S et al. Serum levels of P-selectin in men with high-functioning autism. Br. J. Psychiatry 193(4), 338-339 (2008).
43. Tsuchiya KJ, Hashimoto K, Iwata Y et al. Decreased serum levels of platelet-endothelial adhesion molecule (PECAM-1) in subjects with high-functioning autism: a negative correlation with head circumference at birth. Biol. Psychiatry 62(9), 1056-1058 (2007). (Pubitemid 47562363)
44. Dettmer K, Hanna D, Whetstone P, Hansen R, Hammock BD. Autism and urinary exogenous neuropeptides: development of an on-line SPE-HPLC-tandem mass spectrometry method to test the opioid excess theory. Anal. Bioanal. Chem. 388(8), 1643-1651 (2007). (Pubitemid 47173083)
45. Cass H, Gringras P, March J et al. Absence of urinary opioid peptides in children with autism. Arch. Dis. Child. 93(9), 745-750 (2008).
46. Tordjman S, Anderson GM, Botbol M et al. Pain reactivity and plasma β-endorphin in children and adolescents with autistic disorder. PLoS One 4(8), e5289 (2009).
47. Onore C, Enstrom A, Krakowiak P et al. Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders. J. Neuroimmunol. 216(1-2), 126-129 (2009).
48. Heuer L, Ashwood P, Schauer J et al. Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms. Autism Res. 1(5), 275-283 (2008).
49. Enstrom A, Krakowiak P, Onore C et al. Increased IgG4 levels in children with autism disorder. Brain Behav. Immun. 23(3), 389-395 (2009).
50. Croen LA, Goines P, Braunschweig D et al. Brain-derived neurotrophic factor and autism: maternal and infant peripheral blood levels in the Early Markers for Autism (EMA) Study. Autism Res. 1(2), 130-137 (2008).
51. Bailey AR, Giunta BN, Obregon D et al. Peripheral biomarkers in autism: secreted amyloid precursor protein-a as a probable key player in early diagnosis. Int. J. Clin. Exp. Med. 1(4), 338-344 (2008).
52. Blardi P, de Lalla A, DAmbrogio T et al. Long-term plasma levels of leptin and adiponectin in Rett syndrome. Clin. Endocrinol. (Oxf). 70(5), 706-709 (2008).
53. Emanuele E, Boso M, Brondino N et al. Increased serum levels of high mobility group box 1 protein in patients with autistic disorder. Prog. Neuropsych. Biol. Psychiatry 34(4), 681-683 (2010).
54. Kajizuka M, Miyachi T, Matsuzaki H et al. Serum levels of platelet-derived growth factor BB homodimers are increased in male children with autism. Prog. Neuropsych. Biol. Psychiatry 34(1), 154-158 (2010).
55. Warren RP, Odell JD, Warren WL, Burger RA, Maciulis A, Torres AR. Is decreased blood plasma concentration of the complement C4B protein associated with attention-deficit hyperactivity disorder? J. Am. Acad. Child Adolesc. Psychiatry 34(8), 1009-1014 (1995).
56. Kopecková M, Paclt I, Goetz P. Polymorphisms and low plasma activity of dopamine-β-hydroxylase in ADHD children. Neuro. Endocrinol. Lett. 27(6), 748-754 (2006). (Pubitemid 46138633)
57. Castagnola M, Messana I, Inzitari R et al. Hypo-phosphorylation of salivary peptidome as a clue to the molecular pathogenesis of autism spectrum disorders. J. Proteome Res. 7(12), 5327-5332 (2008).
58. Corbett BA, Kantor AB, Schulman H et al. A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins. Mol. Psychiatry 12(3), 292-306 (2007). (Pubitemid 46328511)
59. MacLean B, Tomazela DM, Shulman N et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26(7), 966-968 (2010).